Shared decision-making is an approach where physicians and patients work together to
determine a personalized treatment course. Such an approach is integral to patient-centered …

Chronic rhinosinusitis (CRS) is a sino-nasal chronic inflammatory disease, occurring in 5–
15% of the general population. CRS with nasal polyps (CRSwNP) is present in up to 30% of …

Background: The management of chronic rhinosinusitis with nasal polyps (CRSwNP) is
evolving, with an emphasis on treating the underlying type 2 inflammation. Objective: The …

Uncontrolled severe chronic rhinosinusitis with nasal polyps (CRSwNP) is the most
bothersome phenotype of chronic rhinosinusitis; it is typically characterized by a type 2 …

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a heterogeneous disease treated with
medication or surgery. For recalcitrant type 2 CRSwNP, biological agents have been …

Background: European patients with chronic rhinosinusitis with nasal polyps (CRSwNP)
have had only limited occasions to unite to have their voices heard, hence missing the …

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a predominantly type 2 inflammation-
mediated disease of the nasal mucosa and paranasal sinuses with an under-recognized …

Background Chronic rhinosinusitis with nasal polyps (CRSwNP) has been traditionally
managed with a combination of topical and systemic medical therapy as well as endoscopic …

Background Chronic rhinosinusitis with nasal polyps (CRSwNPs) is the most challenging
form of CRS to treat. Clinical practices vary widely among physicians around the world, often …

The development of biologics targeting various aspects of type 2 inflammation for the
treatment of chronic rhinosinusitis with nasal polyps (CRSwNP) will provide clinicians with …